PHARMACEUTICAL AGENT FOR ORAL ADMINISTRATION, ISRAEL FOR IRON AND MAGNESIUM SUBSTITUTION TAPI

摘要

The product consists of a combination of one or more pharmaceutically and physiologically tolerated iron compound(s), one or more pharmaceutically and physiologically tolerated magnesium compound(s) and, if the magnesium compound(s) contain(s) no chlorine atoms which can dissociate in aqueous media and saturate the available magnesium valencies, one or more pharmaceutically and physiologically tolerated compound(s) which provide(s) chlorine ions in aqueous media, together with conventional pharmaceutical solvents and/or diluents and/or auxiliaries. …??It is possible with this product to administer magnesium and, where appropriate, calcium compounds simultaneously with iron compounds without the absorption of iron being reduced thereby.